Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
Diabetologia, Volume 58, No. 3, Year 2015
Notification
URL copied to clipboard!
Aims/hypothesis: The evidence on the association between pioglitazone use and bladder cancer is contradictory, with many studies subject to allocation bias. The aim of our study was to examine the effect of exposure to pioglitazone on bladder cancer risk internationally across several cohorts. The potential for allocation bias was minimised by focusing on the cumulative effect of pioglitazone as the primary endpoint using a time-dependent approach.